Exceptional Case of Spontaneous Ovarian Hyperstimulation Syndrome in Complete Molar Pregnancy: A Case Study
Main Article Content
Abstract
Spontaneous ovarian hyperstimulation syndrome (OHS) is an uncommon condition. We report the case of a 38-year-old woman admitted to the emergency department with vaginal bleeding, pelvic pain, and an extraordinarily high human chorionic gonadotropin (hCG) level of 1,000,000 mIU/mL. Uterine aspiration confirmed a complete hydatidiform mole. Ten days post-discharge, she returned, exhibiting severe abdominal pain, vomiting, an hCG level of 46,769 mIU/mL, and ultrasound evidence of theca lutein cysts (right ovary: 1329 cm³; left ovary: 500 cm³) along with ascites. Suspected of having OHS, she was hospitalized for clinical management. Treatment included intravenous hydration, analgesia, thromboprophylaxis, and daily laboratory tests, leading to symptomatic improvement despite rising hCG levels. After a 35-day hospital stay, she commenced chemotherapy at a specialized cancer hospital. This case emphasizes the importance of healthcare professionals being alert and aware of the possibility of this diagnostic suspicion in such cases, particularly highlighting the need for hospitalization in moderate to severe instances.
Article Details

This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Humaidan P, Nelson SM, Devroey P, Coddington CC, Schwartz LB, Gordon K, et al. Ovarian hyperstimulation syndrome: review and new classification criteria for reporting in clinical trials. Hum Reprod. 2016;31:1997–2004.
Delbaere A, Smits G, Olatunbosun O, Pierson R, Vassart G, Costagliola S. New insights into the pathophysiology of ovarian hyperstimulation syndrome: what makes the difference between spontaneous and iatrogenic syndrome? Hum Reprod. 2004 Mar;19(3):486–9.
Ngan HYS, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, et al. Diagnosis and management of gestational trophoblastic disease: 2021 update. Int J Gynaecol Obstet. 2021 Oct;155(Suppl 1):86–93.
Winchar K, Rosenthal M, Elliott JE, Corbett C. Ovarian hyperstimulation syndrome complicating spontaneous molar pregnancy: a case report and review of the literature. J Obstet Gynaecol Can. 2022 Jan;44(1):71–4.
Royal College of Obstetricians and Gynaecologists. The management of ovarian hyperstimulation syndrome [Internet]. London; 2016 [cited 2022 Jun 18]. Available from: https://www.rcog.org.uk/guidance/browse-all-guidance/green-top-guidelines/the-management-of-ovarian-hyperstimulation-syndrome-green-top-guideline-no-5/
Braga A, Sun SY, Maestá I, Uberti E. Doença trofoblástica gestacional [Internet]. São Paulo; 2019. Report No.: Protocolo Febrasgo – Obstetrícia, no 23. Available from: www.febrasgo.org.br
Cabar FR. Ovarian hyperstimulation syndrome in a spontaneous singleton pregnancy. Einstein (Sao Paulo). 2016 May 24;14(2):231–4.
Sanchez M, et al. Síndrome de hiperestimulación ovárica espontáneo en un embarazo con una mola invasiva: reporte de un caso. Rev Iberoam Fertil Reprod Hum. 2020;37.
Berkowitz RS, Goldstein DP. Clinical practice. Molar pregnancy. N Engl J Med. 2009 Apr 16;360(16):1639-45. doi: 10.1056/NEJMcp0900696. PMID: 19369669.
Cho HW, Ouh YT, Min KJ, Lee NW, Lee S, Song JY, et al. The impact of previous cesarean section on the risk for post-molar gestational trophoblastic neoplasia. Gynecol Oncol. 2020 Mar;156(3):606–10.
Li J, Gwilt P. The effect of malignant effusions on methotrexate disposition. Cancer Chemother Pharmacol. 2002;50(5):373–82.
Freitas F, Braga A, Viggiano M, Velarde LGC, Maesta I, Uberti E, et al. Gestational trophoblastic neoplasia lethality among Brazilian women: a retrospective national cohort study. Gynecol Oncol. 2020 Aug;158(2):452–9.